These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3169371)

  • 1. Clinical significance of the negative inotropic effect of disopyramide.
    Kenedi PP
    J Int Med Res; 1988; 16(4):257-63. PubMed ID: 3169371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography.
    Wisenberg G; Zawadowski AG; Gebhardt VA; Prato FS; Goddard MD; Nichol PM; Rechnitzer PA; Gryfe-Becker B
    Am J Cardiol; 1984 May; 53(9):1292-7. PubMed ID: 6711431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of disopyramide after administration of conventional capsules and sustained-release tablets.
    Nauta IL; van de Calseyde J; Hertzberger DP
    Curr Med Res Opin; 1983; 8(8):582-93. PubMed ID: 6653136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].
    Angermann C; Autenrieth G
    Klin Wochenschr; 1981 Jul; 59(14):803-11. PubMed ID: 7265814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of conventional oral dose of disopyramide on left atrial and ventricular functions.
    Arakawa M; Miwa H; Noda T; Kagawa K; Nishigaki K; Ito Y; Kawada T; Hirakawa S
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):253-9. PubMed ID: 8314654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral disopyramide therapy on left ventricular function.
    Greene AC; Iskandrian AS; Hakki AH; Kane SA; Segal BL
    Chest; 1983 Mar; 83(3):480-4. PubMed ID: 6825481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of and adverse effects of disopyramide. Comparison of capsules, controlled release tablets and placebo in patients with chronic ventricular arrhythmias.
    Ekelund LG; Nilsson E; Walldius G
    Eur J Clin Pharmacol; 1986; 29(6):673-7. PubMed ID: 3519236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of disopyramide on the electrocardiogram and ventricular function in the unanesthetized dog.
    Crosby HH; Hamlin RL; Strauch SM
    J Vet Pharmacol Ther; 1984 Sep; 7(3):167-75. PubMed ID: 6492243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Ritmilen and allapinin on central hemodynamics and myocardial contractility of patients with heart rhythm disorders].
    Asymbekova EU; Bunin IuA; Pomerantsev EV; Firstova MI; Bakashvili NG
    Kardiologiia; 1987 Apr; 27(4):68-71. PubMed ID: 3155396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systolic time intervals in evaluation of the negative inotropic effect after single oral doses of mexiletine and disopyramide.
    Rousson D; Piolat C; Galleyrand J; Ferry S; Boissel JP
    Eur J Clin Pharmacol; 1986; 30(3):263-8. PubMed ID: 3732360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of mexiletine and disopyramide after cardioplegic arrest.
    Moritz A; Eckersberger F; Losert U; Probst P; Schreiner W; Wolner E
    Eur Surg Res; 1989; 21(6):327-35. PubMed ID: 2633930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of disopyramide on left ventricular function: assessment by radionuclide cineangiography.
    Gottdiener JS; Dibianco R; Bates R; Sauerbrunn BJ; Fletcher RD
    Am J Cardiol; 1983 May; 51(9):1554-8. PubMed ID: 6405606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of concurrent oral administration of propranolol and disopyramide on cardiac function in healthy men.
    Cathcart-Rake WF; Coker JE; Atkins FL; Huffman DH; Hassanein KM; Shen DD; Azarnoff DL
    Circulation; 1980 May; 61(5):938-45. PubMed ID: 7363436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the effects of disopyramide phosphate on left ventricular function and the peripheral circulation.
    Di Bianco R; Gottdiener JS; Singh SN; Fletcher RD
    Angiology; 1987 Feb; 38(2 Pt 2):174-83. PubMed ID: 3103491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
    Thadani U; Manyari D; Gregor P; Olowoyeye J; Leach A; West RO; Parker JO
    Cathet Cardiovasc Diagn; 1981; 7(1):27-34. PubMed ID: 7214518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
    Paulk EA
    Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of disopyramide in patients after open-heart surgery.
    Naqvi N; Thompson DS; Morgan WE; Williams BT; Coltart DJ
    Br Heart J; 1979 Nov; 42(5):587-94. PubMed ID: 316334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of radionuclide ventriculography for assessment of changes in myocardial performance induced by disopyramide phosphate.
    Kowey PR; Friedman PL; Podrid PJ; Zielonka J; Lown B; Wynne J; Holman BL
    Am Heart J; 1982 Oct; 104(4 Pt 1):769-74. PubMed ID: 6812403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.